328 PHCL

Introduction to Poison & Information Services

Course description:

This course explores the fundamental aspects of drug information. It is designed as an introductory course to teach the students the basic principles of drug information pertaining to retrieval, evaluation and communication skills. In addition, the course should help student not only to understand the type of drug information available but also what sources of information are appropriate to use in a variety of situations

Course Objectives:

Upon successful completion of this course, student should be able to:

 

 

1-Identify and list different types of information resources available.

2-Discuss the advantages and disadvantages of the tertiary, secondary, and primary literature.

3-Develop critical understanding of the strengths and limitations of these resources (scope, type of information, arrangement, method of access, structure, and application of frequently used drug information tertiary resources.)

4-Understand the different secondary databases, the search strategy and article citation and retrieval process involved.

5-Demonstrate proficiency in the use of computerized information databases

6-Understand and differentiate the type of information cited in a biomedical journal (original article, review article, case report, editorial, etc)

7-Conduct a systematic search of the tertiary, secondary, and primary literature in order to retrieve appropriate drug information to answer a specific request

8-Evaluate online drug information sites for appropriateness and quality.

9-Formulate a drug information response based on the requestor’s level of understanding

10- Develop sufficient communication skills through verbal and written activities

11-Demonstrate sufficient skills to perform appropriate calculations.

12- List literature resources utilized to manage topic specific questions (poison, herbal, pregnancy, evidence-based medicine, etc)

13-List other activities performed by drug information pharmacist (drug evaluation, DUE, ADR reporting, DI newsletter, etc